Capital International Investors Spring Works Therapeutics, Inc. Transaction History
Capital International Investors
- $511 Billion
- Q4 2024
A detailed history of Capital International Investors transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Capital International Investors holds 2,361,746 shares of SWTX stock, worth $138 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,361,746
Previous 1,225,667
92.69%
Holding current value
$138 Million
Previous $39.3 Million
117.29%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$417 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$327 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$202 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$191 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$175 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.63B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...